Journal Of Clinical Oncology (jco) Podcast
Should Gemtuzumab Ozogamicin Be Re-added to the Therapeutic Armamentarium for Acute Myeloid Leukemia?
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:11:12
- More information
Informações:
Synopsis
Although gemtuzumab ozogamicin has been withdrawn from the marketplace, three randomized trials prompt review of that decision.
